Zobrazeno 1 - 10 of 275 pro vyhledávání: '"T. Chisesi"'
1
Akademický článek
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
Autor: G. Santini, C. De Souza, S. Aversa, C. Patti, L. Tedeschi, M. Candela, A. Olivieri, T. Chisesi, A. Rubagotti, R. Centurioni, V. Nardi, M. Congiu, M. Gennaro, M. Truini
Publikováno v: Brazilian Journal of Medical and Biological Research, Vol 37, Iss 5, Pp 719-728 (2004)
The objective of this multicenter prospective study was to determine the clinical efficacy and toxicity of a polychemotherapeutic third generation regimen, VACOP-B, with or without radiotherapy as front-line therapy in aggressive localized non-Hodgki
Externí odkaz: https://doaj.org/article/9efaa5000afe4941bb7930d225af2a80
Zobrazit plný text záznamu
2
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: Therapeutic perspective
Autor: P. Mazza, S. Tura, M. Bocchia, P. L. Zinzani, F. Gherlinzoni, F. Mandelli, M. P. Anselmo, G. Papa, M. Antimi, P. G. Gobbi, A. Porcellini, V. Rizzoli, L. Resegotti, A. Levis, L. Deriu, A. Chierichini, F. Ciccone, R. Fanin, G. Castoldi, G. L. Scapoli, V. Liso, T. Chisesi, L. Rancan, B. Amurri
Publikováno v: European Journal of Haematology. 45:22-24
In an ongoing phase II study we are evaluating the role of alpha-2b recombinant interferon in Hodgkin's disease; the study design includes patients with high-risk parameters who are treated by combination chemotherapy MOPP, ABVD, MOPP + ABVD or equiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b9643451535c6df70e101a7356b9d4
https://doi.org/10.1111/j.1600-0609.1990.tb00900.x
Zobrazit plný text záznamu
3
State of the art in the treatment of CLL
Autor: T. Chisesi
Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Volume: 31 Supplement 2, Pages: 51-56, Published: AUG 2009
Revista Brasileira de Hematologia e Hemoterapia v.31 suppl.2 2009
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults in the Western world and predominantly affects the elderly. Although CLL remains incurable with standard treatments, important progress in treatment, which classically i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476bcda4023ee1236bedc3952fa124eb
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000800014&lng=en&tlng=en
Zobrazit plný text záznamu
4
Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission
Autor: R. Sertoli, A. M. Congiu, Elena Rossi, A. Contu, Gino Santini, A. Porcellini, A. M. Carella, D. Pierluigi, Daniele Scarpati, T. Chisesi, O. Vinante, T. D’Amico, V. Rizzoli, P Coser
Publikováno v: Annals of Oncology. 2:181-185
Summary Thirty-six successive adult patients with lymphoblastic lymphoma entered a study of sequential chemotherapy consisting of an intensive LSA2-L2-type protocol to induce first complete remission. Eighteen patients in first CR (median age 22 year
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8d6978e096879052b3a3c29261f3e95
https://doi.org/10.1093/annonc/2.suppl_2.181
Zobrazit plný text záznamu
6
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia
Autor: AZS Rohatiner, R Bassan, R Battista, MJ Barnett, W Gregory, J Lim, J Amess, A Oza, T Barbui, M Horton, T Chisesi, TA Lister
Publikováno v: British Journal of Cancer
In a study conducted at St Bartholomew's Hospital between 1972 and 1982, using moderately intensive therapy (OPAL/HEAV'D), a low blast count at presentation (less than 10 x 10(9) 1(-1)) and common ALL (C-ALL) phenotype correlated favourably with dura
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02442e7b79d39cf422baeb8c9d3a6d97
http://europepmc.org/articles/PMC1971462
Zobrazit plný text záznamu
7
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG
Autor: Sandro Nati, Gino Santini, Mauro Spriano, R. Centurioni, M. Candela, Mario Roberto Sertoli, Caterina Patti, A. Contu, R. Vimercati, G. Marino, Ignazio Majolino, L. Tedeschi, Alessandra Rubagotti, A. Olivieri, A. Porcellini, C.C. de Souza, T. Chisesi, S. Aversa, Atto Billio, Monica Crugnola, M. Brunori, A. M. Congiu
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 16(12)
Background: There is not univocal concordance for using high-dose sequential therapy (HDS) as first-line treatment for aggressive non-Hodgkin's lymphoma (NHL). We designed this study to evaluate the usefulness of HDS followed by high-dose therapy (HD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1a149c531faf5bc8d7e7f069b6a962c
https://pubmed.ncbi.nlm.nih.gov/16157621
Zobrazit plný text záznamu
8
Meta-analysis to evaluate the role of interferon in follicular lymphoma
Autor: M. Unterhalt, Philippe Solal-Celigny, T. Chisesi, A. Aviles, A. Z. S. Rohatiner, Walter M Gregory, Bruce A. Peterson, E. Borden, R. Arranz, A. Hagenbeek, T. A. Lister, R. I. Fisher
Publikováno v: Journal of clinical oncology, 23(10), 2215-2223. American Society of Clinical Oncology
Purpose To determine whether interferon (IFN) -α2, when given with or following chemotherapy, influences response rate, remission duration, and survival in newly diagnosed patients with follicular lymphoma. Patients and Methods Ten phase III studies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e7403044982d871b9314e72ddbb743
https://pubmed.ncbi.nlm.nih.gov/15684317
Zobrazit plný text záznamu
9
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
Autor: R. Centurioni, A. Rubagotti, T. Chisesi, S. Aversa, M. Gennaro, Mauro Truini, M. Congiu, Gino Santini, L. Tedeschi, Valentina Nardi, C.C. de Souza, Caterina Patti, M. Candela, A. Olivieri
Publikováno v: Brazilian Journal of Medical and Biological Research, Vol 37, Iss 5, Pp 719-728 (2004)
Brazilian Journal of Medical and Biological Research, Volume: 37, Issue: 5, Pages: 719-728, Published: MAY 2004
Brazilian Journal of Medical and Biological Research v.37 n.5 2004
Brazilian Journal of Medical and Biological Research
Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
The objective of this multicenter prospective study was to determine the clinical efficacy and toxicity of a polychemotherapeutic third generation regimen, VACOP-B, with or without radiotherapy as front-line therapy in aggressive localized non-Hodgki
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d57307df1dec784ce6b464bafed895
http://hdl.handle.net/11567/211313
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje